1. Home
  2. WRAP vs BOLD Comparison

WRAP vs BOLD Comparison

Compare WRAP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • BOLD
  • Stock Information
  • Founded
  • WRAP 2016
  • BOLD 2018
  • Country
  • WRAP United States
  • BOLD United States
  • Employees
  • WRAP N/A
  • BOLD N/A
  • Industry
  • WRAP Ordnance And Accessories
  • BOLD
  • Sector
  • WRAP Industrials
  • BOLD
  • Exchange
  • WRAP Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • WRAP 68.8M
  • BOLD 81.0M
  • IPO Year
  • WRAP N/A
  • BOLD 2024
  • Fundamental
  • Price
  • WRAP $1.70
  • BOLD $2.95
  • Analyst Decision
  • WRAP
  • BOLD Strong Buy
  • Analyst Count
  • WRAP 0
  • BOLD 3
  • Target Price
  • WRAP N/A
  • BOLD $23.00
  • AVG Volume (30 Days)
  • WRAP 191.1K
  • BOLD 57.8K
  • Earning Date
  • WRAP 10-15-2024
  • BOLD 11-11-2024
  • Dividend Yield
  • WRAP N/A
  • BOLD N/A
  • EPS Growth
  • WRAP N/A
  • BOLD N/A
  • EPS
  • WRAP N/A
  • BOLD N/A
  • Revenue
  • WRAP $7,269,000.00
  • BOLD N/A
  • Revenue This Year
  • WRAP N/A
  • BOLD N/A
  • Revenue Next Year
  • WRAP N/A
  • BOLD N/A
  • P/E Ratio
  • WRAP N/A
  • BOLD N/A
  • Revenue Growth
  • WRAP 0.99
  • BOLD N/A
  • 52 Week Low
  • WRAP $1.21
  • BOLD $2.82
  • 52 Week High
  • WRAP $7.01
  • BOLD $15.24
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 56.79
  • BOLD N/A
  • Support Level
  • WRAP $1.71
  • BOLD N/A
  • Resistance Level
  • WRAP $1.93
  • BOLD N/A
  • Average True Range (ATR)
  • WRAP 0.16
  • BOLD 0.00
  • MACD
  • WRAP 0.01
  • BOLD 0.00
  • Stochastic Oscillator
  • WRAP 61.70
  • BOLD 0.00

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: